Medicine has no reliable way to stop them once they take hold
Marburg, Ebola, and Hantavirus lead with mortality rates exceeding 40%, transmitted through animal contact and bodily fluids with limited treatment protocols available. Avian flu H5N1 poses pandemic risk despite low human transmission; dengue surges in Latin America with record cases driven by climate change and urbanization.
- Marburg mortality rate has reached 88 percent in documented outbreaks
- Hantavirus pulmonary form carries mortality near 40 percent
- Avian flu H5N1 mortality exceeds 50 percent in human cases
- Lassa fever affects 100,000-300,000 people annually in West Africa
- Latin America recorded record dengue cases between 2024-2026
El Diario analyzes ten of the world's most lethal viruses identified by WHO as epidemiological priorities, examining transmission mechanisms, mutation capacity, and clinical manifestations from Marburg to dengue.
The world's health systems are locked in a quiet race against ten viruses that kill with brutal efficiency. The World Health Organization has identified these pathogens as epidemiological priorities not because they are the most lethal—though several are—but because they move unpredictably, mutate without warning, and in many cases, medicine has no reliable way to stop them once they take hold.
Marburg arrived first in the historical record, discovered in 1967 in German and Serbian laboratories after workers handled infected green monkeys from Uganda. It belongs to the same viral family as Ebola, and it kills with similar ferocity. The disease triggers a hemorrhagic fever that cascades into organ failure in most cases. Mortality rates have reached 88 percent in documented outbreaks. The virus lives naturally in fruit bats, but spreads between humans through direct contact with blood and bodily fluids—a transmission route that makes hospitals themselves dangerous places. Patients develop sudden high fever and severe headache, then by the third day, violent diarrhea and abdominal pain. Between days five and seven, they begin to bleed from the mouth, nose, and digestive tract. Without intervention, the body shuts down.
Ebola, the more widely known cousin, emerged as a major threat during the 2014-2016 West African epidemic. Of its six known species, Zaire ebolavirus is the most aggressive, penetrating cells and disabling the immune system's early defenses. It spreads from infected animals—chimpanzees, bats—to humans, then person to person. The disease announces itself with sudden fever, muscle pain, and weakness, followed by vomiting, diarrhea, and rash. In advanced stages, patients hemorrhage internally and externally while their white blood cells and platelets collapse.
Hantavirus kills differently. Two clinical forms exist: one attacks the kidneys, the other the lungs. The pulmonary form carries a mortality rate near 40 percent and spreads through inhaled particles from infected rodent urine, feces, or saliva. Patients develop fever and muscle pain, then within days, severe respiratory distress as fluid fills the lungs. The kidney form progresses toward shock and acute renal failure.
Avian influenza—H5N1 and H7N9—represents a different kind of threat. Human-to-human transmission remains rare, but when it occurs, mortality exceeds 50 percent. The virus has spread through wild and domestic bird populations worldwide, forcing the culling of millions of animals. The UN Food and Agriculture Organization warns that constant circulation in farms creates opportunity for genetic recombination that could enable efficient human transmission, potentially triggering a global epidemic. Symptoms range from mild upper respiratory infection to rapidly progressive pneumonia, acute respiratory distress, and in some cases, neurological damage including encephalitis.
Lassa fever affects between 100,000 and 300,000 people annually in West Africa, particularly Nigeria, Liberia, and Sierra Leone. The multimammate rat carries it. Eighty percent of infections cause no symptoms, but severe cases produce hemorrhaging and permanent deafness in a quarter of survivors. The virus is endemic to the region, with outbreaks clustering during dry seasons when rodents invade human settlements seeking food.
Junín virus causes Argentine hemorrhagic fever and primarily affects rural workers. It is one of the few on this list with an effective vaccine—Candid #1—which has reduced incidence in endemic provinces. Crimea-Congo hemorrhagic fever spreads through Hyalomma ticks across Africa, Eastern Europe, and Asia, affecting livestock and wildlife before reaching humans. Machupo virus, discovered in the 1960s, causes Bolivian hemorrhagic fever with mortality between 5 and 30 percent and can spread person to person, elevating risk in hospitals and homes. Kyasanur Forest Disease, identified in India's Karnataka state, follows a deceptive two-phase course: apparent recovery followed by neurological complications including encephalitis.
Dengue stands apart as the world's most widespread mosquito-borne viral disease. Between 2024 and 2026, Latin America has recorded unprecedented case numbers driven by rising temperatures and uncontrolled urban expansion into natural areas. The virus exists in four serotypes, and infection with different variants dramatically increases the risk of severe dengue. The Pan American Health Organization reports that prevention remains centered on controlling the Aedes aegypti mosquito, while vaccines like Qdenga aim to reduce hospitalizations in heavily affected countries. The disease presents as high fever, severe headache, pain behind the eyes, muscle and joint pain, and in severe cases, abdominal pain, persistent vomiting, rapid breathing, and hemorrhaging. What unites all ten viruses is not their individual lethality but their capacity to spread, mutate, and overwhelm the systems designed to contain them.
Citações Notáveis
The UN Food and Agriculture Organization warns that constant circulation of avian flu in farms creates opportunity for genetic recombination that could enable efficient human transmission, potentially triggering a global epidemic.— UN Food and Agriculture Organization
The Pan American Health Organization reports that dengue prevention remains centered on controlling the Aedes aegypti mosquito, while vaccines like Qdenga aim to reduce hospitalizations in heavily affected countries.— Pan American Health Organization
A Conversa do Hearth Outra perspectiva sobre a história
Why does the WHO group these ten together? They seem to work in completely different ways.
They do work differently, but they share something more important than mechanism—they're all capable of causing outbreaks that spread faster than we can respond. Lethality alone doesn't make the list. A virus that kills 90 percent of people but infects only one person a year is less of a threat than one that kills 5 percent but spreads exponentially.
So it's about the combination of how easily they spread and how many people they kill.
Exactly. And mutation capacity. A virus that stays stable is predictable. These ten have shown they can change, adapt, find new hosts. That's what keeps epidemiologists awake.
Marburg and Ebola seem almost identical in how they kill.
They're cousins in the same viral family, and yes, the hemorrhagic cascade is similar—organ failure, bleeding, shock. But Marburg was identified first, in 1967. Ebola emerged later and became more visible during the West African crisis. Both are terrifying because there's no cure, only supportive care and hope the body fights back.
What about dengue? It seems less severe than the others.
In its classic form, yes. But dengue is everywhere now. Millions of cases in Latin America alone. The real danger is when someone gets infected with one serotype, recovers, then encounters a different one. That second infection can trigger severe dengue—hemorrhaging, organ damage, death. Scale matters. One Marburg patient is a tragedy. One million dengue cases means thousands die and tens of thousands are hospitalized.
Is there anything we can actually do about these?
Some have vaccines—Junín does, dengue vaccines are rolling out. Vector control helps with dengue and Crimea-Congo. But for Marburg, Ebola, Hantavirus? We have no antivirals. We can only isolate patients, support their organs, and hope. That's why surveillance matters so much. Catching an outbreak early, before it spreads, is often the only tool we have.